Overview

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MOL4239 is effective in adult subjects with mild to moderate plaque psoriasis by comparing two target lesions in which each subject will apply MOL4239 ointment to one target lesion and placebo ointment to the contralateral target lesion twice a day for 28.5 consecutive days.
Phase:
Phase 2
Details
Lead Sponsor:
Moleculin, LLC